PRESS RELEASE published on 05/13/2025 at 07:30, 6 months 22 days ago Inside Information / Other news releases Sensorion announces successful adoption of all resolutions at Combined General Meeting. Results available on company's website Biotechnology Resolutions Combined General Meeting Sensorion Hearing Loss
BRIEF published on 05/06/2025 at 07:35, 6 months 29 days ago Sensorion to Present at ASGCT Annual Meeting Gene Therapy Sensorion Hearing Loss ASGCT Meeting DFNB1A
PRESS RELEASE published on 05/06/2025 at 07:30, 6 months 29 days ago Inside Information / Other news releases Sensorion announces participation at ASGCT Annual Meeting to present gene therapy research for hearing loss. Company focuses on developing innovative therapies. ASGCT 28th meeting details included Research Gene Therapy ASGCT Sensorion Hearing Loss
BRIEF published on 04/25/2025 at 07:35, 7 months 9 days ago Sensorion's Gene Therapy Presentation at 2025 ASPO Annual Meeting Gene Therapy Clinical Trial Hearing Loss SENS-501 Pediatric Otolaryngology
PRESS RELEASE published on 04/25/2025 at 07:30, 7 months 9 days ago Inside Information / Other news releases Sensorion announces Pr. Natalie Loundon presenting at 2025 ASPO Annual Meeting on SENS-501 gene therapy for hearing loss in children with DFNB9, Audiogene trial details and Sensorion's focus on developing therapies for hearing loss disorders Gene Therapy Sensorion Hearing Loss Audiogene Trial Pr. Natalie Loundon
BRIEF published on 04/18/2025 at 09:29, 7 months 16 days ago Sensorion prepares its General Meeting of May 12, 2025 Shareholders Biotechnology General Meeting Sensorion Hearing Loss
PRESS RELEASE published on 04/18/2025 at 09:24, 7 months 16 days ago Inside Information / Other news releases Sensorion provides preliminary documents for the Combined Shareholders' General Meeting of May 12, 2025 at Hotel Square Louvois, Paris. Shareholders can request meeting documents and view details on company website Shareholders' Meeting General Meeting Preliminary Documents Sensorion Hearing Loss
BRIEF published on 04/16/2025 at 07:35, 7 months 18 days ago Sensorion is organizing a symposium at the ISIET 2025 conference Gene Therapy Hearing Loss SENS-401 Medical Innovations Sensorion Symposium
PRESS RELEASE published on 04/16/2025 at 07:30, 7 months 18 days ago Inside Information / Other news releases Sensorion to host a symposium at ISIET's International Conference on Inner Ear Therapies in Marrakech, Morocco, on April 26, 2025, focusing on hearing loss innovation and gene therapies Sensorion Gene Therapies Symposium ISIET Inner Ear Therapies
BRIEF published on 04/02/2025 at 07:35, 8 months 2 days ago Sensorion Appoints Amit Munshi as Chairman of the Board Board Of Directors Hearing Loss Therapies Sensorion Leadership Amit Munshi Appointment Biotech Executive Experience
Published on 12/05/2025 at 02:35, 4 hours 12 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 47 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 42 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 47 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 17 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 57 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 22 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 32 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 37 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 47 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 2 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 3 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 46 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
